Welcome to our dedicated page for US BANCORP DE SEC filings (Ticker: USB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on US BANCORP DE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into US BANCORP DE's regulatory disclosures and financial reporting.
U.S. Bancorp is offering Senior Medium-Term Notes, Series Callable Fixed Rate Notes due March 19, 2046 with a fixed interest rate of 5.60% per annum. The Notes are callable, in whole but not in part, on each March 19, June 19, September 19 and December 19 beginning March 19, 2029 through December 19, 2045, at 100% of principal plus accrued interest, subject to the Business Day Convention and Interest Accrual Convention.
The Notes pay interest annually on the 19th of March beginning March 19, 2027, are issued in $1,000 minimum denominations, and will be delivered in book-entry form through DTC. Selling commissions may be up to $40.00 per $1,000 principal amount; proceeds and aggregate principal amount are set on the final pricing supplement.
U.S. Bancorp is offering Senior Medium-Term Notes — Callable Fixed Rate Notes due March 19, 2041 with a stated interest rate of 5.35% per annum. These notes pay annual interest on March 19, beginning March 19, 2027, and may be redeemed at the issuer's option on specified Redemption Dates.
The Notes have $1,000 minimum denominations, a 30/360 day count, redemption dates quarterly on the 19th from June 19, 2028 through December 19, 2040, and will be unsecured senior obligations of U.S. Bancorp. Selling commissions may be up to $40.00 per $1,000.
U.S. Bancorp has released its 2026 proxy detailing proposals, board changes, and governance practices ahead of the virtual annual meeting on April 21, 2026. Shareholders are asked to elect 12 directors, approve an advisory vote on executive compensation, and ratify Ernst & Young LLP as auditor for the 2026 fiscal year, with the board recommending a “FOR” vote on all three items.
The proxy highlights a planned leadership transition: after more than 40 years at the company, Executive Chairman Andrew Cecere will retire from the board at the 2026 meeting, and CEO and President Gunjan Kedia will also become Chairman. Roland Hernandez will continue as Lead Independent Director. The filing emphasizes an independent, skills-diverse board, detailed committee responsibilities, and strong governance features such as majority voting for directors, proxy access, no poison pill, and robust board and committee evaluation and education processes.
The board also created a new Technology Committee effective January 1, 2026 to oversee technology strategy, modernization, artificial intelligence, and cybersecurity, while the Risk Management Committee continues holistic oversight of key financial and non-financial risks. U.S. Bancorp underscores its ethics focus, noting recognition as one of the World’s Most Ethical Companies for the 11th consecutive year in 2025, and encourages shareholders to vote electronically by the April 20, 2026 proxy deadline.
U.S. Bancorp filed an 8-K reporting that on March 9, 2026 it established a new medium-term note program. Under this program, the company may issue Medium-Term Notes, Series EE (Senior) and Series FF (Subordinated), collectively referred to as the Notes.
The Series EE Notes are issued under the company’s existing 1991 senior indenture with Citibank, N.A., as amended and supplemented by an Officers’ Certificate and Company Order dated March 9, 2026. The Series FF Notes are issued under the same 1991 indenture as amended by 1993 and 2017 supplements, also with terms set by a March 9, 2026 Officers’ Certificate and Company Order.
The Notes are registered under the Securities Act of 1933 using a shelf registration statement on Form S‑3 (File No. 333-294133). The filing also lists related exhibits, including a distribution agreement with U.S. Bancorp Investments, Inc. and other agents, the forms of the global notes, and a legal opinion and consent from Willkie Farr & Gallagher LLP.
Stern John C reported acquisition or exercise transactions in this Form 4 filing.
US Bancorp (USB) Vice Chair and CFO John C. Stern received an equity grant of 25,227 shares of common stock on March 5, 2026. This award was granted at no cash cost to him and increased his directly owned common stock to 107,485 shares.
The grant consists of restricted stock units that vest 33% on each of March 5, 2027 and March 5, 2028, and 34% on March 5, 2029. These units represent 40% of his 2026 long-term incentive award, with the remaining 60% in performance-based units that will be determined in early 2029 based on company performance from 2026 through 2028.
U.S. Bancorp is issuing a prospectus supplement to offer senior (Series EE) and subordinated (Series FF) medium-term notes due nine months or more from issue.
The supplement states that specific terms, pricing, offering procedures and commissions will be set forth in one or more pricing supplements. It notes the notes are unsecured, not FDIC-insured, may be structurally subordinated to subsidiary creditors, and that a pricing supplement will control discrepant terms.
Stark Lisa R reported acquisition or exercise transactions in this Form 4 filing.
US Bancorp EVP and Controller Lisa R. Stark received an equity award of 15,767 shares of common stock on March 5, 2026. The award was granted at no cash cost and is structured as restricted stock units.
The restricted stock units vest 33% on each of March 5, 2027 and March 5, 2028, and 34% on March 5, 2029. After this grant, Stark directly holds 53,166 common shares. She also has 1,225 shares held indirectly through a 401(k) plan based on a plan report dated February 27, 2026.
Runkel Mark G. reported acquisition or exercise transactions in this Form 4 filing.
US Bancorp vice chair Mark G. Runkel reported an equity award and updated holdings in company stock. He received 13,356 shares of common stock at a price of $0.00 per share as a grant classified as a long-term incentive award, increasing his directly held common stock to 117,933 shares.
The grant consists of restricted stock units that vest 33% on March 5, 2027, 33% on March 5, 2028, and 34% on March 5, 2029. These units represent 40% of his 2026 long-term incentive value, with the remaining 60% in performance-based restricted stock units to be earned based on company performance from 2026 through 2028, with final amounts determined in early 2029. He also reported indirect holdings of 458 shares through a 401(k) plan and 2,846 shares through a trust, based on a plan report dated February 27, 2026.
U.S. Bancorp senior executive Arijit Roy reported equity-based compensation awards. He acquired 13,356 shares of common stock at a grant price of $0.0000, bringing his direct common stock holdings to 47,412 shares after the award.
Roy also acquired 2,175 units of Deferred Compensation Plan Participation at a reference price of $52.3700, which are payable in common stock after his employment with U.S. Bancorp ends. Footnotes explain that the 2026 long-term incentive award is split between time-vested restricted stock units and performance-based restricted stock units, with vesting running from March 5, 2027 through March 5, 2029 and performance measured over 2026–2028.